Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Change in Accured Expenses (2021 - 2025)

P3 Health Partners (PIII) has disclosed Change in Accured Expenses for 5 consecutive years, with -$7.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Accured Expenses fell 16.92% year-over-year to -$7.6 million, compared with a TTM value of -$11.3 million through Sep 2025, down 377.53%, and an annual FY2024 reading of -$8.1 million, down 184.5% over the prior year.
  • Change in Accured Expenses was -$7.6 million for Q3 2025 at P3 Health Partners, down from $4.6 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $4.6 million in Q2 2025 and bottomed at -$9.9 million in Q4 2024.
  • Average Change in Accured Expenses over 5 years is $256187.5, with a median of $1.4 million recorded in 2021.
  • The sharpest move saw Change in Accured Expenses crashed 107.11% in 2022, then surged 92.84% in 2024.
  • Year by year, Change in Accured Expenses stood at $1.3 million in 2021, then soared by 73.82% to $2.2 million in 2022, then increased by 3.55% to $2.3 million in 2023, then plummeted by 534.33% to -$9.9 million in 2024, then increased by 23.36% to -$7.6 million in 2025.
  • Business Quant data shows Change in Accured Expenses for PIII at -$7.6 million in Q3 2025, $4.6 million in Q2 2025, and $1.6 million in Q1 2025.